Clifton Bancorp Inc (NASDAQ:CSBK) files its latest 10-K with SEC for the fiscal year ended on March 31, 2017. Clifton Bancorp Inc is a savings and loan holding company. It operates as a community-oriented financial institution offering traditional financial services to consumers and businesses in its market area. Clifton Bancorp Inc has a market cap of $372.740 million; its shares were traded at around $16.53 with a P/E ratio of 75.16 and P/S ratio of 12.60. The dividend yield of Clifton Bancorp Inc stocks is 1.46%. Clifton Bancorp Inc had annual average EBITDA growth of 9.70% over the past ten years.
For the last quarter Clifton Bancorp Inc reported a revenue of $7.95 million, compared with the revenue of $7.13 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $30.6 million, an increase of 8.8% from last year. For the last five years Clifton Bancorp Inc had an average revenue growth rate of 4.1% a year.
The reported diluted earnings per share was 21 cents for the year, a decline of 4.5% from the previous year. Over the last five years Clifton Bancorp Inc had an average EPS decline of 6% a year. The Clifton Bancorp Inc had a decent operating margin of 22.53%, compared with the operating margin of 28.26% a year before. The 10-year historical median operating margin of Clifton Bancorp Inc is 39.51%. The profitability rank of the company is 5 (out of 10).
Best Financial Stocks To Own For 2019: NEW GOLD INC.(NGD)
- [By Paul Ausick]
New Gold Inc. (NYSEAMERICAN: NGD) dropped about 3.8% Thursday to post a new 52-week low of $2.28. Shares closed at $2.37 on Wednesday and the stock’s 52-week high is $4.25. Volume was about 15% below the daily average of around 5.9 million shares. The company had no specific news.
- [By Paul Ausick]
New Gold Inc. (NYSEAMERICAN: NGD) dropped about 2.9% Monday to post a new 52-week low of $2.35. Shares closed at $2.42 on Friday and the stock’s 52-week high is $4.25. Volume was about 10% below the daily average of around 5.8 million shares. The gold mining company had no news.
- [By Lisa Levin] Gainers
ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook.
vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results.
RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results.
Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter.
Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales.
Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings.
MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma.
New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor.
Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session.
Himax Technologies, Inc. (NASDAQ: HIMX) shares rose
Best Financial Stocks To Own For 2019: Intuitive Surgical Inc.(ISRG)
- [By Brian Feroldi]
TransEnterix (NYSEMKT:TRXC) recently surprised investors on the upside when it reported its first-quarter results. The company’sSenhancesurgical system is off to a fast start right out of the gate, and it has attracted a lot of positive attention from the medical community. This just goes to show how much demand is out there for analternative to Intuitive Surgical’s (NASDAQ: ISRG)dominant da Vinci platform.
- [By Anders Bylund]
Shares of Intuitive Surgical (NASDAQ:ISRG) rose 31.1% in the first half of 2018, according to data from S&P Global Market Intelligence. The maker of the da Vinci line of robotic surgery tools crushed Wall Street’s expectations in both of the earnings reports that were presented in this six-month span.
- [By Sean Williams]
The VISE acronym stands for:
Visa (NYSE:V) Intuitive Surgical (NASDAQ:ISRG) Sirius XM Holdings (NASDAQ:SIRI) Electronic Arts (NASDAQ:EA)
Each of these four companies brings clear-cut competitive advantages to the table that should allow it to handily outperform the broader market (and the FANG stocks).
- [By Motley Fool Staff]
Right now, it’s time for that yearly review of the ones he picked to honor the month, and also the briefly famous pregnant giraffe: five companies, and the first letters of their tickers spelled out A-P-R-I-L. They were Axon Enterprise(NASDAQ:AAXN), Grupo Aeroportuario del Pacific(NYSE:PAC), ResMed(NYSE:RMD), Intuitive Surgical (NASDAQ:ISRG), and Live Nation(NYSE:LYV).
- [By Motley Fool Staff]
Stock No. 4: Let’s go to the “I” stock from our April stocks a year ago. That’s one of my favorite companies, a stock that I own, and have held for more than a decade, and that would be Intuitive Surgical (NASDAQ:ISRG), the maker of the da Vinci robot, the surgical robot.
Best Financial Stocks To Own For 2019: Atlas Energy, L.P.(ATLS)
- [By Max Byerly]
Atlas Energy Group (OTCMKTS: ATLS) and Transglobe Energy (NASDAQ:TGA) are both small-cap oils/energy companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.